V. Shridhar
Division of Experimental Pathology
Mayo Clinic/Foundation
200 First Street SW
Rochester
USA
Name/email consistency: high
- Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Shridhar, V., Bible, K.C., Staub, J., Avula, R., Lee, Y.K., Kalli, K., Huang, H., Hartmann, L.C., Kaufmann, S.H., Smith, D.I. Cancer Res. (2001)